SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML. Di Mambro A, Arroyo-Berdugo Y, Fioretti T, Randles M, et al. Oncogene 2023;42:3670-3683.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Di Mambro A, Arroyo-Berdugo Y, Fioretti T, Randles M, et al. SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML. Oncogene 2023;42:3670-3683.
PMID: 37891368